Thomas L. Gutshall
Direktor/Vorstandsmitglied bei Pacific Medical Research Foundation
Profil
Thomas L.
Gutshall is the founder of CEPHEID, which was founded in 1996.
He served as Chairman from 2002 to 2013.
Currently, he holds director positions at Profusa, Inc., Pacific Medical Research Foundation, Silver Bullet Therapeutics, Inc., and is an advisor at 1Flourish Capital LLC.
Previously, he served as a Director at CV Therapeutics, Inc. from 1994 to 2009, and as a Director at Metrika, Inc. and Satoris, Inc. He also served as Executive Vice President at Syntex Corp.
from 1989 to 1994.
Mr. Gutshall received his undergraduate degree from the University of Delaware in 1960.
Aktive Positionen von Thomas L. Gutshall
| Unternehmen | Position | Beginn |
|---|---|---|
| Pacific Medical Research Foundation | Direktor/Vorstandsmitglied | - |
Profusa, Inc.
 Profusa, Inc. Electronic Equipment/InstrumentsElectronic Technology Profusa, Inc. provides biofeedback for chronic disease management and healthy livingg. It develops an in vivo human sensor system to generate real-time data on the levels of various body chemistries. Its first application being a glucose monitoring system. The company was founded by William McMillan, Kristen Lloyd Helton and Natalie Ann Wisniewski in 2009 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 01.01.2012 |
| Silver Bullet Therapeutics, Inc. | Direktor/Vorstandsmitglied | - |
1Flourish Capital LLC
 1Flourish Capital LLC Investment ManagersFinance 1Flourish Capital LLC (1Flourish Capital) is a venture capital firm founded in 2016 by David A. Lane, Reid Rutherford, Skip Vaccarello and Andrew Miller. The firm is headquartered in Mountain View, California. | Berater | - |
Ehemalige bekannte Positionen von Thomas L. Gutshall
| Unternehmen | Position | Ende |
|---|---|---|
Satoris, Inc.
 Satoris, Inc. Miscellaneous Commercial ServicesCommercial Services Satoris, Inc. develops tests for neurological diseases. It develops tests for neurological diseases such as Alzheimer's, Parkinson's, Multiple Sclerosis, and Diabetic Neuropathy. The company was founded in 2003 by Tony Wyss-Coray and Sandip Ray and is headquartered in Menlo Park, CA. | Direktor/Vorstandsmitglied | 01.01.2011 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Direktor/Vorstandsmitglied | 17.04.2009 |
| Syntex Corp. | Corporate Officer/Principal | 01.12.1994 |
Metrika, Inc.
 Metrika, Inc. BiotechnologyHealth Technology Metrika Inc. manufactures and markets disease-monitoring products. It also manufactures other chronic condition products. The company was founded in 1994 by Michael P. Allen and is headquartered in Sunnyvale, CA. | Direktor/Vorstandsmitglied | - |
| CEPHEID | Vorstandsvorsitzender | 22.04.2002 |
Ausbildung von Thomas L. Gutshall
| University of Delaware | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
CEPHEID
 CEPHEID Medical SpecialtiesHealth Technology CEPHEID develops, manufactures and markets fully-integrated systems that perform genetic analysis. The firm's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company was founded by Thomas L. Gutshall, William McMillan, Kurt Petersen, Greg Kovacs and M. Allen Northrup on March 4, 1996 and is headquartered in Sunnyvale, CA. | Health Technology |
Metrika, Inc.
Metrika, Inc. BiotechnologyHealth Technology Metrika Inc. manufactures and markets disease-monitoring products. It also manufactures other chronic condition products. The company was founded in 1994 by Michael P. Allen and is headquartered in Sunnyvale, CA. | Health Technology |
| Pacific Medical Research Foundation | |
| Syntex Corp. | Health Technology |
Satoris, Inc.
Satoris, Inc. Miscellaneous Commercial ServicesCommercial Services Satoris, Inc. develops tests for neurological diseases. It develops tests for neurological diseases such as Alzheimer's, Parkinson's, Multiple Sclerosis, and Diabetic Neuropathy. The company was founded in 2003 by Tony Wyss-Coray and Sandip Ray and is headquartered in Menlo Park, CA. | Commercial Services |
Profusa, Inc.
Profusa, Inc. Electronic Equipment/InstrumentsElectronic Technology Profusa, Inc. provides biofeedback for chronic disease management and healthy livingg. It develops an in vivo human sensor system to generate real-time data on the levels of various body chemistries. Its first application being a glucose monitoring system. The company was founded by William McMillan, Kristen Lloyd Helton and Natalie Ann Wisniewski in 2009 and is headquartered in San Francisco, CA. | Electronic Technology |
| Silver Bullet Therapeutics, Inc. | |
1Flourish Capital LLC
1Flourish Capital LLC Investment ManagersFinance 1Flourish Capital LLC (1Flourish Capital) is a venture capital firm founded in 2016 by David A. Lane, Reid Rutherford, Skip Vaccarello and Andrew Miller. The firm is headquartered in Mountain View, California. | Finance |
